[CLSTR]
API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 2 sources · 18 days · First seen · Last updated

AI-designed bacteriophage therapy development

Overview

Researchers have utilized artificial intelligence to combat antibiotic resistance by designing customized bacteriophages. In laboratory settings, scientists at Stanford University and the Arc Institute used an AI system named Evo to create a phage cocktail that successfully overcame resistance in certain E. coli strains. This research also identified the CBASS system, which bacteria use to detect and defend against viral attacks.

Following these laboratory successes, medical professionals achieved a milestone by treating a patient with an AI-designed virus cocktail to combat a life-threatening bacterial infection. This experimental therapy, which targeted multi-resistant E. coli, was approved by the US Food and Drug Administration (FDA) and developed by the company Radical Numerics. While these advancements offer precision in eliminating specific pathogens, experts have raised biosecurity concerns regarding the ability to compose viral genomes using generative AI.

Entities

University of Utah Health · Stanford University · Johns Hopkins Center for Health Security · E. coli · Arc Institute

Timeline

  1. [HEALTH] 2 sources
    Doctors use AI-designed viruses to treat antibiotic-resistant infection

    Doctors have administered the first AI-designed bacteriophage cocktail to treat a patient with multi-resistant E. coli, marking a breakthrough in the fight against antibiotic resistance.

  2. [TECHNOLOGY] 2 sources
    AI-designed bacteriophages overcome E. coli resistance in lab tests

    AI-designed bacteriophages have successfully overcome E. coli resistance in lab tests, while new research reveals how bacterial immune systems detect viral attacks, offering paths for new therapies.

Sources

leinetal24.de · merkur-online.de